(1)
Rouanet, J.; Joulie, I.; Lambert, C.; D’Incan, M. Real-Life Use of Bexarotene for T-Cell Cutaneous Lymphoma Management: Efficacy and Tolerance With Low Doses. Acta Derm Venereol 2022, 102, adv00746.